SkinBioTherapeutics PLC

Holistic Skin Care: Skincare Revolution in the Making?

By Alex Langton & Elric Langton | 16 January 2025

Mike, Elric, and I all have a financial interest in SkinBioTherapeutics.

News from SkinBioTherapeutics might be a tad quiet right now, but we are ramping up our efforts because there is a skincare revolution about to take place in Holland, of all places is where the planned official launch at in-cosmetics in April 2025 will see the lysate positioned as a commercially available active ingredient within Sederma’s product catalogue, giving SkinBiotix™ technology its first big push into the global skincare market. Well, that’s where the shock & awe will take place for many industry experts. SkinBioTherapeutics is quietly yet confidently positioning itself at the nexus of science, beauty, and wellness, which includes oral care. With its proprietary SkinBiotix™ technology platform, the company seems poised to capitalise on the burgeoning trends in cosmetics and functional beauty. Partnering with industry giant Croda International, specifically its cosmetics division Sederma, SkinBioTherapeutics is spearheading a scientific revolution with its lysate-based approach to skincare – and the timing couldn’t be more perfect.

The SkinBiotix™ platform harnesses lysates derived from probiotic bacteria to enhance skin health, focusing on improving the skin barrier, accelerating wound healing, and even tackling infections. In the words of Dr Damian Kelly, Croda’s Vice President of Innovation & Technology Development, this “fascinating project” is nearing commercialisation, promising to “break new scientific ground” in the cosmetic industry. Dr Kelly’s excitement was palpable when he revealed unexpected technical benefits observed during scale-up activities – a discovery that could open up supplementary applications for this active ingredient.

Let’s be clear: (I know, I hate it when politicians use this phrase) The industry is often dominated by marketing gimmicks and pseudoscience; a clinically proven, evidence-backed technology like SkinBiotix is the real deal. It’s no surprise that Croda, a global leader in cosmetic products, is pulling out all the stops to bring this innovation to market. For SkinBioTherapeutics, this partnership is more than a vote of confidence – it’s an accelerant, thrusting the company into the limelight of a rapidly evolving industry, but the focus for investors is the share price. Forget it for now; you can’t control it, just enjoy the ride ahead of the thrust!